Publications by authors named "Isabel Redondo"

Claim this Profile
M
Mirikizumab impact on disease clearance in patients with moderately to severely active ulcerative colitis: analysis of a pre-specified LUCENT trial endpoint.
Jean-Frederic Colombel, Jianmin Wu, Taku Kobayashi, Baojin Zhu, Jerome Paulissen, Isabel Redondo

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Postbiotic Administration on Canine Health: A Systematic Review and Meta-Analysis.
Diego Paul Bonel-Ayuso, Javier Pineda-Pampliega, Paloma Martinez-Alesón García, Montserrat Fernandez-Muela, Jesús de la Fuente, Beatriz Isabel Redondo

Microorganisms· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn's Disease: Results from the Japanese CONFIDE Study.
Toshifumi Hibi, Taku Kobayashi, Masaru Tanaka, Satoshi Osaga, Alison J Potts Bleakman, Isabel Redondo

Adv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive cell therapies in thoracic malignancies: a comprehensive review.
Yago Garitaonaindia, Marta Martínez-Cutillas, Maria Uribarren, Isabel Redondo, Virginia Calvo

Clin Transl Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
Geert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, Bruce E Sands, Scott Lee, Isabel Redondo

Inflamm Bowel Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis.
Axel Dignass, Claire Ainsworth, Susanne Hartz, Niels Dunnewind, Isabel Redondo

Adv Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme.
Silvio Danese, Axel Dignass, Katsuyoshi Matsuoka, Marc Ferrante, Millie Long, Isabel Redondo

J Crohns Colitis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Sensory Quality and Shelf Life of a Bioactive Essence Rich in Monounsaturated Fatty Acids and Antioxidants, Obtained from Eco-Sustainable Iberian Ham.
Eva Bruna-García, Marta Miguel-Castro, Beatriz Isabel-Redondo

Foods· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study.
Raja Atreya, Isabel Redondo, Petra Streit, Marijana Protic, Susanne Hartz

Crohns Colitis 360· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
Melania Dovizio, Susanne Hartz, Carlotta Buzzoni, Isabel Redondo, Marijana Nedeljkovic Protic

Adv Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials.
Rish K Pai, Geert D'Haens, Taku Kobayashi, Bruce E Sands, Simon Travis, Isabel Redondo

Expert Rev Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and outcomes in patients with inflammatory bowel disease receiving standard and escalated doses of targeted therapies: findings from a global real-world study.
Axel Dignass, Isabel Redondo, Petra Streit, Susanne Hartz, Gamze Gurses

Curr Med Res Opin· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
Marla Dubinsky, Alison Potts Bleakman, Remo Panaccione, Toshifumi Hibi, Stefan Schreiber, Isabel Redondo

Am J Gastroenterol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.
Fernando Magro, Rish K Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo

J Crohns Colitis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in Europe.
Javier P Gisbert, Petra Streit, Isabel Redondo, Susanne Hartz, Hannah Knight

Curr Med Res Opin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of two triterpenoids from , one of them with anti-oomycete activity against , and insights into its biosynthetic pathway.
L Fernández-Calleja, M García-Domínguez, B Isabel Redondo, J L Gómez Martín, C J Villar

Front Plant Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Method for Obtaining a Bioactive Essence Extracted from Iberian Ham Fat Rich in MUFA and Antioxidants.
Eva Bruna-García, Beatriz Isabel Redondo, Marta Miguel Castro

Molecules· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal model.
J Fernández, V García de la Fuente, M T Fernández García, J Gómez Sánchez, B Isabel Redondo

Lipids Health Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Isabel Redondo

Therap Adv Gastroenterol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C treated with peginterferon alfa plus ribavirin in clinical practice.
José Velosa, Fátima Serejo, Tiago Bana, Isabel Redondo, Adélia Simão

Hepatogastroenterology· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes.
Gregory R Ferrier, Isabel Redondo, Jiequan Zhu, Mary G Murphy

Cardiovasc Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis